Local Lipschitz regularity for degenerate elliptic systems

We start presenting an $L^{\infty}$-gradient bound for solutions to non-homogeneous $p$-Laplacean type systems and equations, via suitable non-linear potentials of the right hand side. Such a bound implies a Lorentz space characterization of Lipschitz regularity of solutions which surprisingly turns out to be independent of $p$, and that reveals to be the same classical one for the standard Laplacean operator. In turn, the a priori estimates derived imply the existence of locally Lipschitz regular solutions to certain degenerate systems with critical growth of the type arising when considering geometric analysis problems, as recently emphasized by Rivi\`er

Response Assessment of NovoTTF-100A Versus Best Physician\u27s Choice Chemotherapy in Recurrent Glioblastoma

The NovoTTF-100A device emits frequency-tuned alternating electric fields that interfere with tumor cell mitosis. In phase III trial for recurrent glioblastomas, NovoTTF-100A was shown to have equivalent efficacy and less toxicity when compared to Best Physician\u27s Choice (BPC) chemotherapy. We analyzed the characteristics of responders and nonresponders in both cohorts to determine the characteristics of response and potential predictive factors. Tumor response and progression were determined by Macdonald criteria. Time to response, response duration, progression-free survival (PFS) ± Simon-Makuch correction, overall survival (OS), prognostic factors, and relative hazard rates were compared between responders and nonresponders. Median response duration was 7.3 versus 5.6 months for NovoTTF-100A and BPC chemotherapy, respectively (P = 0.0009). Five of 14 NovoTTF-100A responders but none of seven BPC responders had prior low-grade histology. Mean cumulative dexamethasone dose was 35.9 mg for responders versus 485.6 mg for nonresponders in the NovoTTF-100A cohort (P \u3c 0.0001). Hazard analysis showed delayed tumor progression in responders compared to nonresponders. Simon-Makuch-adjusted PFS was longer in responders than in nonresponders treated with NovoTTF-100A (P = 0.0007) or BPC chemotherapy (P = 0.0222). Median OS was longer for responders than nonresponders treated with NovoTTF-100A (P \u3c 0.0001) and BPC chemotherapy (P = 0.0235). Pearson analysis showed strong correlation between response and OS in NovoTTF-100A (P = 0.0002) but not in BPC cohort (P = 0.2900). Our results indicate that the response characteristics favor NovoTTF-100A and data on prior low-grade histology and dexamethasone suggest potential genetic and epigenetic determinants of NovoTTF-100A response

The Effect of Field Applications of Insecticides on Honey Bees

Reports of tests of new insecticides have tended to minimize the practical dangers to beekeeping when these toxicants are applied to crops in bloom. The idea is current that these insecticides are harmless to bees if applied during hours when bees are not on the field. An examination of one alfalfa-seed area, where bee losses from commercial applications were reported, prompted a more critical examination to determine the effect of field applications of these insecticides on bees. This paper is a report of field experiments near Logan. Utah, with early-morning applications of DDT, chlordane, parathion, and toxaphene to alfalfa in flower

A Real-Time Smart Sensor for High-Resolution Frequency Estimation in Power Systems

Power quality monitoring is a theme in vogue and accurate frequency measurement of the power line is a major issue. This problem is particularly relevant for power generating systems since the generated signal must comply with restrictive standards. The novelty of this work is the development of a smart sensor for real-time high-resolution frequency measurement in accordance with international standards for power quality monitoring. The proposed smart sensor utilizes commercially available current clamp, hall-effect sensor or resistor as primary sensor. The signal processing is carried out through the chirp z-transform. Simulations and experimental results show the efficiency of the proposed smart sensor

Clinical Recovery in First-Episode Psychosis

Introduction: Generally agreed outcome criteria in psychosis are required to evaluate the effectiveness of new treatment strategies. The aim of this study is to explore clinical recovery in first-episode patients, defined by meeting criteria for both symptomatic and functional remission. Method: In a sample of first-episode patients (N = 125), symptomatic and functional remission during the last 9 months of a 2-year follow-up period were examined, as well as recovery and its predictors. Results: Half the patients (52.0%) showed symptomatic remission and a quarter (26.4%) functional remission, while one-fifth (19.2%) met both criteria sets and were considered recovered. Recovery was significantly associated with short duration of untreated psychosis and better baseline functioning. Conclusion: Most functionally remitted patients were also symptomatically remitted, while a minority of symptomatically remitted patients were also functionally remitted. Treatment delay may affect chance of recovery

Clinically Relevant Effect of a New Intranasal Therapy (MP29-02) in Allergic Rhinitis Assessed by Responder Analysis

Acknowledgements This study was funded by MedaPharma.Peer reviewedPublisher PD

Auditory communication in domestic dogs: vocal signalling in the extended social environment of a companion animal

Domestic dogs produce a range of vocalisations, including barks, growls, and whimpers, which are shared with other canid species. The source–filter model of vocal production can be used as a theoretical and applied framework to explain how and why the acoustic properties of some vocalisations are constrained by physical characteristics of the caller, whereas others are more dynamic, influenced by transient states such as arousal or motivation. This chapter thus reviews how and why particular call types are produced to transmit specific types of information, and how such information may be perceived by receivers. As domestication is thought to have caused a divergence in the vocal behaviour of dogs as compared to the ancestral wolf, evidence of both dog–human and human–dog communication is considered. Overall, it is clear that domestic dogs have the potential to acoustically broadcast a range of information, which is available to conspecific and human receivers. Moreover, dogs are highly attentive to human speech and are able to extract speaker identity, emotional state, and even some types of semantic information

Promise and challenges of peptide-poly: ICLC vaccines for adult and pediatric gliomas

We currently run phase I studies of subcutaneous vaccinations with synthetic peptides for glioma-associated antigen (GAA) epitopes emulsified in Montanide-ISA-51 and intramuscular administration of poly-ICLC in HLA-A2+ adult and pediatric patients with gliomas. Primary endpoints were safety and CD8+ T-cell responses against vaccine-targeted GAAs: IL-13Rα2, EphA2, Survivin and WT1 (WT1 in adults only). Adults with WHO grade 2 low-grade glioma (LGG) have an extremely high risk for transformation to high-grade glioma (HGG), and most patients eventually die of the disease. Because patients with LGGs may not be as immuno-compromised as patients with HGG, they may exhibit greater immunological response to and benefit from the vaccines. We conducted a phase I vaccine study with: newly diagnosed high-risk LGG without prior radiation therapy (RT) (Cohort 1); newly diagnosed high-risk LGG with prior RT (Cohort 2); or recurrent LGG (Cohort 3). Cohorts 1, 2, and 3 have enrolled 12, 1, and 10 patients, respectively. No regimen-limiting toxicity has been encountered except for one case with Grade 3 fever (Cohort 1). Cohort 1 patients demonstrated significantly higher magnitude of IFN-γ ELISPOT responses than Cohort 3 patients for all 4 GAA epitopes, suggesting that newly diagnosed patients may have better vaccine-responsiveness than recurrent patients. The magnitude of the IFN-γ ELISPOT responses in this study is significantly higher than that observed in our previous phase I/II study in HGG patients. Median progression-free survival (PFS) periods are 21 months (Cohort 1; range 10-44) and 12 months (Cohort 3; range 3-28). In Cohort 1, 3 patients are still progression-free (32, 33 and 44 months to date). The only patient with large astrocytoma in Cohort 2 has been progression-free for over 54 months since diagnosis. There was a positive trend for IFN-γ ELISPOT responses and PFS. Diffuse brainstem gliomas (BSGs) and other HGGs of childhood carry a dismal prognosis. To date, 24 children were enrolled, 14 with newly diagnosed BSG treated with RT, and 10 with newly diagnosed BSG or HGG treated with RT and concurrent chemotherapy. No dose-limiting non-CNS toxicity was encountered. Five children had symptomatic pseudoprogression, which responded to corticosteroids and was associated with prolonged survival. Nineteen had stable disease for > 2 cycles, 2 had partial responses, and 1 had prolonged disease-free status after surgery. Median survival among the BSG cohort exceeded 13 months. ELISPOT analysis in 15 children showed GAA responses in 12, to IL-13Rα2 in 9, EphA2 in 7, and survivin in 7. Careful monitoring and management of pseudoprogression is warranted